Teaching old drugs new tricks: asthma therapy adjusted by patient perception or noninvasive markers

Gibson P. G.

Source: Eur Respir J 2005; 25: 397-399
Journal Issue: March
Disease area: Airway diseases

PDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Gibson P. G.. Teaching old drugs new tricks: asthma therapy adjusted by patient perception or noninvasive markers. Eur Respir J 2005; 25: 397-399

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Application of biomarkers and patient characteristics to personalize asthma treatment for children
Source: International Congress 2016 – Deep phenotyping to improve treatment outcomes in paediatric asthma
Year: 2016


Use of alternative therapies in patients with asthma and COPD: is there any difference?
Source: Eur Respir J 2005; 26: Suppl. 49, 504s
Year: 2005

Getting approval for new therapeutic medical devices versus drugs: are the differences justified?
Source: Eur Respir Rev 2016; 25: 223-226
Year: 2016


Evidence-based medicines for children: important implications for new therapies at all ages
Source: Eur Respir J 2006; 28: 1069-1072
Year: 2006


New and future developments of therapy for asthma in children
Source: Eur Respir Mon 2012; 56: 224-234
Year: 2012


Foundation doctor knowledge of inhaled devices - Are the old better than the new?
Source: International Congress 2016 – Abstracts in medical education, the web and the internet
Year: 2016


The paradoxes of asthma management: time for a new approach?
Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017
Year: 2017



Internet-based patient education: evaluation of a new tool for young asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 383s
Year: 2004

An evidence-based and step-wise approach to treat pulmonary sarcoidosis with old and new drugs
Source: International Congress 2019 – State of the art session: Interstitial lung diseases
Year: 2019


Who should receive which biologic and why? Current and future approaches in severe asthma patients
Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what?
Year: 2021


A pragmatic guide to choosing biologic therapies in severe asthma
Source: Breathe, 17 (4) 210144; 10.1183/20734735.0144-2021
Year: 2021



Validation of a new inhaled therapeutic algorithm for the stable COPD patient: The COPD easy treatment project
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015


Can asthma patients cope with new treatment regimens in Ukraine?
Source: Eur Respir J 2003; 22: Suppl. 45, 409s
Year: 2003

Happy ever after? A new assessment tool for long-term noninvasive ventilation: the S3-NIV questionnaire
Source: Eur Respir J, 52 (5) 1801969; 10.1183/13993003.01969-2018
Year: 2018



Use of relievers in patients with severe asthma on biologic therapy –a multidisciplinary approach
Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world
Year: 2020


When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma?
Source: Eur Respir J, 58 (3) 2100304; 10.1183/13993003.00304-2021
Year: 2021



Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice
Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies
Year: 2009